跳至主要内容
临床试验/NCT04821414
NCT04821414撤回不适用

Effects of IL-1β and Its Receptor Antagonists in the Treatment of Severe Infection and Inflammatory Storm in Children

Children's Hospital of Fudan University0 个研究点开始时间: 2022年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
主要终点
survival rate

研究概览

简要总结

In severe infective patients who survive the initial inflammatory storm, the immune response often evolves toward a state of immunosuppression, which contributes to increased mortality and severe secondary hospital-acquired infections. However, the role of IL-1β and its receptor antagonists in patients with severe sepsis and septic shock is discussed controversially. To date, the efficacy and safety of IL-1β and its receptor antagonists in children with severe infection is not fully evaluated.

详细描述

The investigators intend to enroll all children who were hospitalized in pediatric intensive care unit of Children's Hospital of Fudan University from January 2022 to December 2023. Children with a PICU length of day less than 48h will be excluded. Patients who met the inclusion criteria will be divided into trial group and control group. Clinical and demographic data, as well as treatment outcome will be collected from the electronic health record.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
29 Days 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Children between 29 days and 18 years old.
  • Severe pneumonia and/or sepsis.
  • Patients were included who meet the guideline for diagnosis and treatment of community-acquired pneumonia in Children (2019) issued by the National Health Commission of the people's Republic of China and/or who meet the International Guide to the 2020 campaign to Save sepsis: management of septic shock and sepsis-related organ dysfunction in children.

排除标准

  • Notifiable infectious diseases.
  • The researcher believes that he is not suitable to participate in other situations in this study.
  • Participants in other clinical trials in the same period.
  • Discharge within 48 hours

结局指标

主要结局

survival rate

时间窗: within 28 days after they discharged from PICU

The death rate of children in 28 days after their discharged from PICU

次要结局

  • length of stay in PICU(within 28 days after they discharged from PICU)

研究者

申办方类型
Other
责任方
Sponsor

相似试验